If manufacturers cannot ensure safe, cost-effective delivery of treatments for rare diseases, access will remain a challenges for many patients living with these conditions.
Danial Arkwell, PhD
Advertisement
Articles by Danial Arkwell, PhD
Advertisement
Latest Updated Articles
How Efficient Cold Chain Logistics Can Change the Lives of Rare Disease PatientsPublished: April 10th 2024 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Mark Cuban Confirms Cost Plus Drugs Partnership
2
The Hidden Costs of Prior Authorizations and Patient Loneliness
3
Pharma Pulse: Telehealth Medication Abortion Requests Surge, FDA Expedites Tzield Review, and New Biopharma Air Network Launches
4
Frontier Scientific Solutions, ATSG Partner to Launch Air Network for Temperature-Controlled Pharmaceuticals
5
